1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

Accelerated chemotherapy with high-dose epirubicin and cyclophosphamide plus r-met-HUG-CSF in locally advanced and metastatic breast cancer

Scinto, A. F., Ferraresi, V., Campioni, N., Tonachella, R., Piarulli, L., Sacchi, I., Giannarelli, D. & Cognetti, F., 1995, In : Annals of Oncology. 6, 7, p. 665-671 7 p.

Research output: Contribution to journalArticle

Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer

Arcangeli, G., Saracino, B., Tirindelli Danesi, D., De Campora, E., Giovinazzo, G., Cognetti, F., Carlini, P., Arcangeli, S. & Mecozzi, A., Oct 2002, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 25, 5, p. 431-437 7 p.

Research output: Contribution to journalArticle

Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas

Vaccaro, V., Fabi, A., Vidiri, A., Giannarelli, D., Metro, G., Telera, S., Vari, S., Piludu, F., Carosi, M. A., Villani, V., Cognetti, F., Pompili, A., Marucci, L., Carapella, C. M. & Pace, A., 2014, In : BioMed Research International. 2014, 351252.

Research output: Contribution to journalArticle

Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?

Catania, G., Malaguti, P., Gasparro, S., Cognetti, F., Vidiri, A. & Fabi, A., Jul 1 2018, In : Oncology (Switzerland). 94, p. 29-33 5 p.

Research output: Contribution to journalArticle

Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU

Schornagel, J. H., Verweij, J., de Mulder, P. H. M., Wildiers, J., Kirkpatrick, A. & Cognetti, F., 1990, In : European Journal of Cancer and Clinical Oncology. 26, 7, p. 857 1 p.

Research output: Contribution to journalArticle

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Placido, S. D., Gallo, C., Laurentiis, M. D., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Mastro, L. D., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 11 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F. & Investigators, GIM., Apr 1 2018, In : The Lancet.Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy for Bladder Cancer: The Chance for Meta-analyses Comparison

Bria, E., Ruggeri, E. M., Pollera, C. F., Terzoli, E., Cognetti, F. & Giannarelli, D., Feb 2007, In : European Urology. 51, 2, p. 576-577 2 p.

Research output: Contribution to journalArticle

Adjuvant chemotherapy for non-small cell lung cancer

Bria, E., Cuppone, F., Cecere, F. L., Milella, M., Nisticò, C., Cognetti, F. & Terzoli, E., May 2007, In : Journal of Thoracic Oncology. 2, 5 SUPPL.1

Research output: Contribution to journalArticle

Adjuvant chemotherapy in muscle-invasive bladder carcinoma: A pooled analysis from phase III studies

Ruggeri, E. M., Giannarelli, D., Bria, E., Carlini, P., Felici, A., Nelli, F., Gallucci, M., Cognetti, F. & Pollera, C. F., Feb 15 2006, In : Cancer. 106, 4, p. 783-788 6 p.

Research output: Contribution to journalArticle

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: An italian, multicenter, randomized phase iii trial

Cognetti, F., Ruggeri, E. M., Felici, A., Gallucci, M., Muto, G., Pollera, C. F., Massidda, B., Rubagotti, A., Giannarelli, D. & Boccardo, F., Mar 2012, In : Annals of Oncology. 23, 3, p. 695-700 6 p.

Research output: Contribution to journalArticle

Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancer [1]

Ferretti, G., Papaldo, P., Fabi, A., Carlini, P., Felici, A. & Cognetti, F., 2006, In : The oncologist. 11, 7, p. 853-854 2 p.

Research output: Contribution to journalArticle

Adjuvant treatment for resected renal cell carcinoma: Are all strategies equally negative? Potential implications for trial design with targeted agents

Massari, F., Bria, E., Maines, F., Milella, M., Giannarelli, D., Cognetti, F., Pappagallo, G., Tortora, G. & Porta, C., Dec 2013, In : Clinical Genitourinary Cancer. 11, 4, p. 471-476 6 p.

Research output: Contribution to journalArticle

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi, A., Giannarelli, D., Moscetti, L., Santini, D., Zambelli, A., Laurentiis, M. D., Caruso, M., Generali, D., Valle, E., Leonardi, V., Cannita, K., Arpino, G., Filippelli, G., Ferretti, G., Giampaglia, M., Montemurro, F., Nisticò, C., Gasparro, S. & Cognetti, F., Dec 2017, In : Future Oncology. 13, 30, p. 2791-2797 7 p.

Research output: Contribution to journalArticle

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi, A., Giannarelli, D., Moscetti, L., Santini, D., Zambelli, A., Laurentiis, M. D., Caruso, M., Generali, D., Valle, E., Leonardi, V., Cannita, K., Arpino, G., Filippelli, G., Ferretti, G., Giampaglia, M., Montemurro, F., Nistico, C., Gasparro, S. & Cognetti, F., Dec 1 2017, In : Future Oncology. 13, p. 2791-2797 7 p.

Research output: Contribution to journalArticle

Advances towards the design and development of personalized non-small-cell lung cancer drug therapy

Vari, S., Pilotto, S., Maugeri-Saccà, M., Ciuffreda, L., Cesta Incani, U., Falcone, I., Del Curatolo, A., Ceribelli, A., Gelibter, A., De Maria, R., Tortora, G., Cognetti, F., Bria, E. & Milella, M., Nov 2013, In : Expert Opinion on Drug Discovery. 8, 11, p. 1381-1397 17 p.

Research output: Contribution to journalArticle

Alfa-epoietin and Anaemia in Gynaecological Cancer

Di Cocco, B., Salesi, N., Fabi, A., Nardoni, C., Ferretti, G., Bossone, G., Ciccarese, M., Savarese, A., Vecchione, A. & Cognetti, F., Mar 2004, In : Anticancer Research. 24, 2 C, p. 1287-1292 6 p.

Research output: Contribution to journalArticle

Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin [1]

Carlini, P., Di Cosimo, S., Ferretti, G., Papaldo, P., Fabi, A., Ruggeri, E. M., Milella, M. & Cognetti, F., Nov 2003, In : Annals of Oncology. 14, 11, p. 1689-1690 2 p.

Research output: Contribution to journalArticle

Altered Expression of FAS System is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy

Botti, C., Buglioni, S., Benevolo, M., Giannarelli, D., Papaldo, P., Cognetti, F., Vici, P., Di Filippo, F., Del Nonno, F., Venanzi, F. M., Natali, P. G. & Mottolese, M., Feb 15 2004, In : Clinical Cancer Research. 10, 4, p. 1360-1365 6 p.

Research output: Contribution to journalArticle

Alternating regimens in recurrent and metastatic squamous cell carcinoma of the head and neck

Cognetti, F., Molinari, A., Carlini, P., Frassineti, G. L., Pinnarò, P. & Marangolo, M., 1987, In : Oncology. 44, 5, p. 270-272 3 p.

Research output: Contribution to journalArticle

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 1 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis

Merola, R., Mottolese, M., Orlandi, G., Vico, E., Cognetti, F., Sperduti, I., Fabi, A., Vitelli, G. & Cianciulli, A. M., Jul 2006, In : European Journal of Cancer. 42, 10, p. 1501-1506 6 p.

Research output: Contribution to journalArticle

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: The COSTANza study

Lazzaro, C., Bordonaro, R., Cognetti, F., Fabi, A., De Placido, S., Arpino, G., Marchetti, P., Botticelli, A., Pronzato, P. & Martelli, E., Apr 9 2013, In : ClinicoEconomics and Outcomes Research. 5, 1, p. 125-135 11 p.

Research output: Contribution to journalArticle

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer

Bria, E., Milella, M., Sperduti, I., Alessandrini, G., Visca, P., Corzani, F., Giannarelli, D., Cerasoli, V., Cuppone, F., Cecere, F. L., Marchetti, A., Sacco, R., Mucilli, F., Malatesta, S., Guetti, L., Vitale, L., Ceribelli, A., Rinaldi, M., Terzoli, E., Cognetti, F. & 1 others, Facciolo, F., Dec 2009, In : Lung Cancer. 66, 3, p. 365-371 7 p.

Research output: Contribution to journalArticle

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis

Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., Rosivatz, E., Woscholski, R., Cognetti, F., Scher, H. I. & Pandolfi, P. P., Mar 1 2010, In : Journal of Clinical Investigation. 120, 3, p. 681-693 13 p.

Research output: Contribution to journalArticle

Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimus

Del Bufalo, D., Ciuffreda, L., Trisciuoglio, D., Desideri, M., Cognetti, F., Zupi, G. & Milella, M., Jun 1 2006, In : Cancer Research. 66, 11, p. 5549-5554 6 p.

Research output: Contribution to journalArticle

Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis

Ferretti, G., Fabi, A., Carlini, P., Papaldo, P., Felici, A. & Cognetti, F., Jul 2007, In : Bone. 41, 1, p. 155-156 2 p.

Research output: Contribution to journalArticle

A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC)

Pino, M. S., Gamucci, T., Mansueto, G., Trapasso, T., Narducci, F., Giampaolo, M. A., Fariello, A. M., Sperduti, I., Ceribelli, A. & Cognetti, F., Jun 2008, In : Lung Cancer. 60, 3, p. 381-386 6 p.

Research output: Contribution to journalArticle

A phase II study of irinotecan alternated with five days bolus of 5- fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer

Van Cutsem, E., Pozzo, C., Starkhammar, H., Dirix, L., Terzoli, E., Cognetti, F., Humblet, Y., Garufi, C., Filez, L., Gruia, G., Cote, C. & Barone, C., Nov 1998, In : Annals of Oncology. 9, 11, p. 1199-1204 6 p.

Research output: Contribution to journalArticle

A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma

De Mulder, P. H. M., Cappelaere, P., Cognetti, F., Verweij, J., Schornagel, J. H., Vermorken, J. B., Kirkpatrick, A. & Lefebvre, J. L., Sep 1994, In : Cancer Chemotherapy and Pharmacology. 33, 5, p. 438-440 3 p.

Research output: Contribution to journalArticle

A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: Changing the natural history of HER2-positive disease

Papaldo, P., Fabi, A., Ferretti, G., Mottolese, M., Cianciulli, A. M., Di Cocco, B., Pino, M. S., Carlini, P., Di Cosimo, S., Sacchi, I., Sperduti, I., Nardoni, C. & Cognetti, F., Apr 2006, In : Annals of Oncology. 17, 4, p. 630-636 7 p.

Research output: Contribution to journalArticle

A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck

Schornagel, J. H., Verweij, J., De Mulder, P. H. M., Cognetti, F., Vermorken, J. B., Cappelaere, P., Armand, J. P., Wildiers, J., Clavel, M., Kirkpatrick, A. & Lefebvre, J. L., 1992, In : Annals of Oncology. 3, 3, p. 223-226 4 p.

Research output: Contribution to journalArticle

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

Geulibter, A. J., Gamucci, T., Pollera, C. F., Di Costanzo, F., Nuzzo, C., Gabriele, A., Signorelli, C., Gasperoni, S., Ferraresi, V., Giannarelli, D., Cognetti, F. & Zeuli, M., Sep 2007, In : Current Medical Research and Opinion. 23, 9, p. 2117-2123 7 p.

Research output: Contribution to journalArticle

A phase II trial of vinorelbine and thiotepa in metastatic breast cancer

Fabi, A., Tonachella, R., Savarese, A., Cirulli, S., Tomao, S., Conte, E. & Cognetti, F., 1995, In : Annals of Oncology. 6, 2, p. 187-189 3 p.

Research output: Contribution to journalArticle

Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy? [5]

Gelibter, A. J., Lonardi, S., Di Segni, S., Fontana, A., Loupakis, F., Cognetti, F. & Labianca, R., Oct 1 2006, In : Journal of Clinical Oncology. 24, 28, p. 4668-4669 2 p.

Research output: Contribution to journalArticle

A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study

Guadagni, F., Ferroni, P., Carlini, S., Mariotti, S., Spila, A., Aloe, S., D'Alessandro, R., Carone, M. D., Cicchetti, A., Ricciotti, A., Venturo, I., Perri, P., Di Filippo, F., Cognetti, F., Botti, C. & Roselli, M., 2001, In : Clinical Cancer Research. 7, 8, p. 2357-2362 6 p.

Research output: Contribution to journalArticle

Are the results obtained in randomized clinical trials on antiemetics sufficiently reproducible in clinical practice?

Rugerri, B., Ballatori, E., Di Orio, F., Roila, F., De Angelis, V., Tonato, M., Del Favero, A., Ciccarese, G., Mattei, A., Bruno, M. L., Angelone, A. M., Basurto, C., Palladino, M. A., Porrozzi, S., Picciafoco, M., Tateo, S., Lucchino, S., Morana, S., Zara, C., Massidda, B. & 31 others, Ionta, M. T., Scanu, A., Mascia, M. G., Ricci, S., Antonuzzo, A., Galli, L., Conte, P. F., Favalli, G., Salinaro, F., Scagliotti, G., Selvaggi, G., Masiero, P., Cortesi, E., Gareri, R., Saltarelli, R., Contu, A., Pazzola, A., Olmeo, N., Picece, V., Nicodemo, M., Recaldin, E., Clerico, M., Grecchi, G., Nuzzo, A., Montinari, F., Donati, D., Alessandroni, P., Dazzi, C., Cognetti, F., Locatelli, M. C. & Buzzi, F., 2000, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 3, p. 267-272 6 p.

Research output: Contribution to journalArticle

Aromatase inhibitors in post-menopausal metastatic breast carcinoma

Carlini, P., Bria, E., Giannarelli, D., Felici, A., Papaldo, P., Fabi, A., Ruggeri, E. M., Milella, M., Nuzzo, C., Cecere, F. L., Gelibter, A., Pino, M. S., Nisticò, C., Cuppone, F., Metro, G., Terzoli, E., Cognetti, F. & Ferretti, G., Jul 2007, In : Expert Opinion on Investigational Drugs. 16, 7, p. 1023-1036 14 p.

Research output: Contribution to journalArticle

A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells

Petrucci, E., Pasquini, L., Petronelli, A., Saulle, E., Mariani, G., Riccioni, R., Biffoni, M., Ferretti, G., Benedetti-Panici, P., Cognetti, F., Scambia, G., Humphreys, R., Peschle, C. & Testa, U., May 2007, In : Gynecologic Oncology. 105, 2, p. 481-492 12 p.

Research output: Contribution to journalArticle

Assessment of PTEN and PI3K status in primary breast cancer and corresponding metastases: Is it worthwhile?

Russillo, M., Di Benedetto, A., Metro, G., Ferretti, G., Papaldo, P., Cognetti, F., Mottolese, M. & Fabi, A., Jul 10 2011, In : Journal of Clinical Oncology. 29, 20, p. 2834-2835 2 p.

Research output: Contribution to journalArticle

Benefit of taxanes as adjuvant chemotherapy for early breast cancer: Pooled analysis of 15,500 patients

Bria, E., Nistico, C., Cuppone, F., Carlini, P., Ciccarese, M., Milella, M., Natoli, G., Terzoli, E., Cognetti, F. & Giannarelli, D., Jun 1 2006, In : Cancer. 106, 11, p. 2337-2344 8 p.

Research output: Contribution to journalArticle

Bevacizumab: One treatment for all the seasons? [5]

Gelibter, A. J., Zeuli, M., Cognetti, F. & Di Segni, S., Jan 20 2008, In : Journal of Clinical Oncology. 26, 3, p. 511 1 p.

Research output: Contribution to journalArticle

Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile

Mottolese, M., Orlandi, G., Sperduti, I., Merola, R., Buglioni, S., Di Benedetto, A., Pinnarò, P., Perracchio, L., Venturo, I., Cognetti, F. & Cianciulli, A., Feb 2007, In : American Journal of Surgical Pathology. 31, 2, p. 247-254 8 p.

Research output: Contribution to journalArticle